The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 20, 2016
Filed:
Feb. 19, 2015
Applicant:
Glaxo Group Limited, Brentford, Middlesex, GB;
Inventors:
Francis Louis Atkinson, Stevenage, GB;
Michael David Barker, Stevenage, GB;
John Liddle, Stevenage, GB;
David Matthew Wilson, Stevenage, GB;
Assignee:
Glaxo Group Limited, Brentford, Middlesex, GB;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/55 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); A61K 31/4725 (2006.01); A61K 45/06 (2006.01); C07D 401/14 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 9/0014 (2013.01); A61K 31/4725 (2013.01); A61K 31/55 (2013.01); A61K 45/06 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01);
Abstract
A compound of formula (I): or a salt thereof;which is an inhibitor of spleen tyrosine kinase (SYK) and therefore potentially of use in treating diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for instance inflammatory diseases and/or allergic conditions, in cancer therapy, specifically heme malignancies, and autoimmune conditions.